Send us a text
What if climbing the digital pathology “mountain” isn’t about reaching the summit alone—but knowing where base camp is, and who you bring with you?
In this episode, I take you inside the Digital Diagnostic Summit in Park City, hosted by Lumea, where fewer than 100 digital pathology leaders gathered to share their journeys, challenges, and solutions.
From resilient metaphors of Everest climbs to practical strategies for workflow ownership, clinical trials, and AI-powered biomarkers, this summit showed that the future of diagnostics is built on collaboration, purpose-driven adoption, and trust in data custodianship.
🔑 Highlights with Timestamps
- [00:03–01:49] Summit kickoff – “Climbing the Digital Pathology Mountain” theme and why this summit feels different.
- [01:49–03:38] Everest keynote – lessons in resilience and why failure is part of innovation.
- [03:38–06:02] Collaboration over competition – why base camp is as important as the summit.
- [06:02–09:18] Workflow ownership – defining value-driven outcomes before choosing tools.
- [09:18–11:35] Data custodianship – protecting patient privacy while enabling ethical research.
- [11:35–15:16] Panel insights – choosing digital tools that integrate into workflows and prevent burnout.
- [15:16–17:31] Horseback networking – why informal conversations matter as much as panels.
- [17:31–19:18] Emerging health tech – 3D printing prosthetics and synthetic blood innovations.
- [19:18–23:54] Personalized biomarkers – outcome-driven diagnostics that move beyond human scoring.
- [23:54–29:16] Digital pathology in trials – Aperture platform launch and patient stratification in global studies.
- [29:16–31:42] Community impact – stories of career transformation and remote adoption.
- [31:42–32:37] Closing thoughts – why intimate summits accelerate adoption and what’s next.
📚 Resources from this Episode
- FDA Journal of Pathology & Informatics – Research on data custodianship and ethical use.
- Proscia Aperture Platform – New tool for clinical trial management and patient identification.
- Astro Zenica Digital Biomarker – Personalized biomarker validated by outcomes.
- Barco Healthcare White Paper – Why display quality matters in pathology.
.
✨ Key Insights from the Summit
✔ Success in digital pathology is not about scaling alone—partnerships matter.
✔ Labs must own their workflows and define outcomes before adopting tools.
✔ Data custodianship is central for protecting privacy while advancing research.
✔ Personalized biomarkers are shifting diagnostics toward outcome-driven AI.
✔ Clinical trials benefit from digital pathology in patient selection and stratification.
✔ Intimate summits provide mentorship, collaboration, and career transformation.
✔ Exciting health tech—from synthetic blood to 3D printing—complements digital pathology innovation.
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!
